A Retrospective Study Assessing the Effect of Topical Tacrolimus Alone or in Combination with Steroids for the Treatment of Shield Ulcers and Corneal Epitheliopathy in Patients with Refractory Allergic Ocular Diseases

Trial Profile

A Retrospective Study Assessing the Effect of Topical Tacrolimus Alone or in Combination with Steroids for the Treatment of Shield Ulcers and Corneal Epitheliopathy in Patients with Refractory Allergic Ocular Diseases

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Tacrolimus (Primary) ; Steroids; Steroids
  • Indications Allergic conjunctivitis; Corneal disorders
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Senju Pharmaceutical
  • Most Recent Events

    • 25 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top